Rapid enzymatic degradation limited oral bioavailability, short plasma half-lives, and pleiotropic signaling profiles confined peptides largely to hormone replacement therapies or niche endocrine indications
It can lead to diabetes, heart problems, and even tumors
Studies have shown positive results indicating that GLP-1 or its analog can reduce hepatic gluconeogenesis and lipogenesis, suggesting that GLP-1 can be used in the treatment of NASH 29,30,31
Do not attempt another dose or skip your next weekly injection
Conclusion: We showed that oral glutathione, 250 mg/d, in both reduced and oxidized forms effectively influences skin properties
A placebo-controlled exploratory study showed that exenatide treatment for 12 weeks did not affect cognitive function in women with IIH [28]